Send feedback

PML p.Ala264=

c.792C>T · rs17849259 · VCV774496

Benign Single submitter
Classification
Benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
rare (popmax 0.874%, nfe)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -4.3GERP -3.5
Overall
CADD5.791PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.874% European (non-Finnish) · 10,295/1,178,490 alleles
Filtering AF 0.859% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.854%
Overall 0.703% 11,293/1,607,302 alleles · rare
Ancestry group Frequency 1 in
European (non-Finnish)grpmax 0.874% 114
Remaining individualsnot grpmax-eligible 0.607% 165
Admixed American 0.378% 264
Finnishnot grpmax-eligible 0.32% 312
Ashkenazi Jewishnot grpmax-eligible 0.302% 331
African / African-American 0.14% 714
Middle Eastern 0.0165% 6,046
South Asian 0.0088% 11,360

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
PML
Protein
p.Ala264=
Coding
c.792C>T
MANE Select
NM_033238
dbSNP
rs17849259
Type
single nucleotide variant
Location
chr15:74023017 (GRCh38)
Gene constraint
LOEUF 0.613 · pLI 0.02 (gnomAD)
Structure
AlphaFold pLDDT 71.17 · 20 PDB
Full PML gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pml-p-ala264 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown